Cargando…
JAK1抑制剂SHR0302和芦可替尼对骨髓增殖性肿瘤SET2细胞系和原代细胞增殖抑制和抗炎作用机制的研究
OBJECTIVE: To explore the effects and molecular mechanism of the selective JAK1inhibitor SHR0302 and Ruxolitinib on myeloproliterative neoplasms（MPN）cell line SET2 and primary cells in vitro. METHODS: Cell proliferation was detected by CCK8 kit. Colony forming experiment was conducted to evaluate er...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342687/ https://www.ncbi.nlm.nih.gov/pubmed/32023730 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.12.006 |